Intramuscular Ketamine to Treat Major Depressive Disorder: A Case Series of Forty Patients
Journal of Psychiatry and Mental Health 2021 DOI: 10.16966/2474-7769.145 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Case report Peer reviewed |
|---|---|
| Topics | Depression Esketamine Ketamine |
| Citations | 7 |
Abstract
Introduction: While the use of ketamine to treat severe depression and post-traumatic stress disorder has been well documented in the literature, fewer studies have investigated the efficacy of Intramuscular (IM) ketamine to treat these conditions.
Citations in the library
Cited by 5
- Use of ketamine for treatment resistant depression: updated review of literature and practical applications to a community ketamine program in Edmonton, Alberta, Canada. Frontiers in Psychiatry 2023
- Ketamine for Bipolar Depression: Biochemical, Psychotherapeutic, and Psychedelic Approaches Frontiers in Psychiatry May 23, 2022
- Real-world patient characteristics, treatment patterns, efficacy and safety of intramuscular ketamine treatment: a retrospective cohort study Research Square February 14, 2022
- Improvement of Mental Health Symptoms in Response to Ketamine Therapy in Medicaid-Eligible Patients Journal of Psychiatry and Mental Health 2024
- Real-world depression, anxiety and safety outcomes of intramuscular ketamine treatment: a retrospective descriptive cohort study BMC Psychiatry October 3, 2022
Cites 10
- Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial American Journal of Psychiatry August 28, 2013
- A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders JAMA Psychiatry March 1, 2017
- Ketamine: a paradigm shift for depression research and treatment Neuron March 1, 2019
- Single, Repeated, and Maintenance Ketamine Infusions for Treatment-Resistant Depression: A Randomized Controlled Trial. American Journal of Psychiatry March 29, 2019
- Esketamine Nasal Spray for Rapid Reduction of Depressive Symptoms in Patients With Major Depressive Disorder Who Have Active Suicide Ideation With Intent: Results of a Phase 3, Double-Blind, Randomized Study (ASPIRE II) The International Journal of Neuropsychopharmacology August 26, 2020
and 5 more in the library